Filter
2211
Filtered Results: 2211
Text search:
specimen
Featured
Recommendations
302
New Publications
638
Language
Document type
No document type
1277
Guidelines
434
Studies & Reports
211
Manuals
107
Strategic & Response Plan
71
Fact sheets
54
Training Material
25
Situation Updates
18
Infographics
6
Videos
3
Online Courses
2
Brochures
1
Dashboards/Maps
1
Resource Platforms
1
Countries / Regions
India
146
South Africa
75
Nigeria
64
Kenya
61
Liberia
59
Sierra Leone
56
Western and Central Europe
50
Africa
44
Global
41
Ethiopia
41
Ghana
36
Tanzania
35
Zambia
35
Rwanda
34
Congo, Democratic Republic of
34
Uganda
31
Malawi
29
Nepal
25
Indonesia
24
West and Central Africa
23
Namibia
23
Zimbabwe
22
Philippines
22
Latin America and the Carribbean
22
Eastern Europe
21
Bangladesh
20
East and Southern Africa
19
Russia
18
Lesotho
17
Guinea
16
Myanmar / Burma
15
Germany
13
Syria
12
Cambodia
12
Mozambique
11
Haiti
11
Middle East and North Africa
11
Eastern Europe and Central Asia
11
Senegal
10
Burkina Faso
9
South–East Asia Region
9
Ukraine
8
Brazil
8
Botswana
8
Madagascar
8
Eswatini/ Swaziland
7
Tajikistan
6
Asia
6
Western Pacific Region
6
Spain
6
Mali
6
South Sudan
6
Pakistan
6
Benin
5
Cameroon
5
Peru
5
USA
5
Angola
5
Afghanistan
4
Italy
4
Côte d’Ivoire / Ivory Coast
4
Somalia
4
Colombia
3
Turkey
3
China
3
France
3
Argentina
3
Vietnam
3
Yemen
3
Palestine
3
Chad
3
Thailand
2
Gambia
2
Togo
2
Burundi
2
Qatar
2
Guinea-Bissau
2
Jordan
2
Saudi Arabia
2
Paraguay
2
Gabon
2
Southern Africa
2
Bolivia
2
Lebanon
2
Central African Republic
2
Libya
2
Iraq
2
North Macedonia
1
Timor Leste/ East Timor
1
El Salvador
1
Australia
1
Iran
1
Laos
1
Uzbekistan
1
Morocco
1
Mauritania
1
Venezuela
1
North America
1
Uruguay
1
Maldives
1
Mauritius
1
United Kingdom
1
Portugal
1
Moldova
1
Sri Lanka
1
Djibouti
1
Egypt
1
Sudan
1
Romania
1
Georgia
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
932
Clinical Guidelines
264
Pharmacy & Technologies
87
Public Health
79
Key Resources
45
Women & Child Health
40
Capacity Building
23
Toolboxes
COVID-19
282
TB
263
Rapid Response
189
HIV
169
Ebola
122
AMR
113
NTDs
82
Pharmacy
36
Caregiver
35
Zika
35
Polio
29
Cholera
28
Mental Health
24
Planetary Health
22
Natural Hazards
18
Refugee
16
Conflict
12
Specific Hazards
10
NCDs
6
Health Financing Toolbox
4
Global Health Education
3
Disability
1
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
CEPI is seeking to raise $3.5 billion to implement CEPI’s next 5-year plan. To mitigate the immediate threat of COVID-19 variants, it is activating key elements of this plan now—and seeking to mobilise a portion of this $3.5 billion in 2021. We have already launched R&D programmes to initiate de...
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm...
Laboratory manual for yellow fever
recommended
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providing routine surveillance testing for yellow fever, wh...
i. A person who is a contact of a probable or confirmed mpox case in the 21 days before the onset of signs or symptoms, and who presents with any of the following: acute onset of fever (>38.5°C), headache, myalgia (muscle pain/body aches), back pain, profound weakness or fatigue.
OR
ii. A per...
Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...
Antimicrobials are medicines, including antibiotics, antivirals, antifungals, and antiparasitics, that are used to prevent and treat infections in humans, animals, and plants. Antimicrobial Resistance (AMR) arises when bacteria, viruses, fungi, and parasites no longer respond to these medicines, ren...
This document serves to provide interim guidance/ recommendations to carry out mpox surveillance activities mainly case investigation, contact tracing and isolation. For the development of this document WHO, UKHSA and CDC guidelines were referred to and adopted within the country context.
THIS LEAFLET AIMS AT GUIDING YOU THROUGH THE VERY FIRST DAYS OF AN OUTBREAK
Communicable Diseases Control in Emergencies
recommended
A field manual
These guidelines have been extracted from the WHO manual Surgical Care at the District
Hospital (SCDH), which is a part of the WHO Integrated Management Package on Emergency
and Essential Surgical Care (IMPEESC).
Refer for details on anaesthesia, head, gunshot and landmine injuries in chapters
